“…In a myeloablative murine model of transplantation, both CD4 ϩ and CD8 ϩ cells from the donor can cause GVHD, but donor CD8 ϩ cells were more than 5-fold more effective than CD4 ϩ cells for preventing graft rejection mediated by host immune cells remaining after myleoablation. 20,21 Similarly, other experimental models have shown that donor-derived bone marrow-resident CD8 ϩ cells, but not CD4 ϩ cells, directly facilitate engraftment of purified hematopoietic stem cells. 22,23 In humans, CD4 ϩ cell removal from donor bone marrow does not hinder engraftment, whereas a correlation between graft failure and depletion of donor CD8 ϩ cells has been reported following myeloablative AHCT.…”